CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing prevalence of chronic diseases
4.1.2. Increasing company initiatives
4.1.3. Benefits of gene panels
4.1.4. Technological advancements such as Next Generation Sequencing (NGS) system
4.2. Market Restraints & Challenges
4.2.1. Issues related to security of generic data
4.2.2. The high cost of testing and erroneous results
4.2.3. Accuracy and standardisation concerns in diagnostic testing
4.3. Market Opportunities
4.3.1. Government initiatives in population sequencing
4.3.2. Emerging markets
CHAPTER 5. GLOBAL GENE PANEL MARKET – BY PRODUCT & SERVICE
5.1. Testing services
5.2. Test kits
CHAPTER 6. GLOBAL GENE PANEL MARKET – BY TECHNIQUE
6.1. Hybridization-based approach
6.2. Amplicon-based approach
CHAPTER 7. GLOBAL GENE PANEL MARKET – BY DESIGN
7.1. Predesigned gene panels
7.2. Customized gene panels
CHAPTER 8. GLOBAL GENE PANEL MARKET – BY APPLICATION
8.1. Cancer Risk Assessment
8.1.1. Syndrome-Specific Gene Panels
8.1.2. High-Penetrance Gene Panels
8.1.3. High and Moderate-Penetrance Gene Panels
8.1.4. Comprehensive Cancer Risk Panels
8.2. Pharmacogenetics
8.3. Diagnosis of Congenital Disorders
8.4. Others
CHAPTER 9. GLOBAL GENE PANEL MARKET – BY END USER
9.1. Research & Academic Institutes
9.2. Hospitals & Diagnostic Laboratories
9.3. Pharmaceutical & Biotechnology Companies
CHAPTER 10. GLOBAL GENE PANEL MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11. GLOBAL GENE PANEL MARKET - COMPANY PROFILES
11.1. Eurofins Scientific SE
11.2. Beijing Genomics Institute
11.3. F. Hoffmann-La Roche AG
11.4. Integrated Dna Technologies
11.5. Genewiz, Inc.
11.6. Novogene Corporation
11.7. Personalis, Inc.
11.8. Gatc Biotech AG
11.9. Archerdx, Inc.
11.10. Qiagen N.V
11.11. Agilent Technologies
11.12. Thermo Fisher Scientific, Inc.
11.13. Illumina, Inc.
11.14. Pacific Biosciences, Inc.
11.15. Macrogen, Inc.
CHAPTER 12. GLOBAL GENE PANEL MARKET - COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13. MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14. APPENDIX
14.1. List of Tables
14.2. List of Figures
